In this study, we demonstrated that the HH pathway is up-regulated in nCRT patients with Mandard 4 and 5 statuses after reviewing the resection material and moreover it may be a key player in the regulation of cancer stemness as shown by the change in the amount CD44+/CD24− CSC population upon HH pathway modulation. Here, CD24 is linked to cancer.